Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JORDAN A SHAVIT

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1518009729
CMS profile
22492
Location
ANN ARBOR, MI

General Payments · PY2018–2024

$181,959.70

  • Reported across 168 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$41,448.07

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $19,011.24 11
BioMarin Pharmaceutical Inc. $10,818.43 9
Novo Nordisk AS $9,868.40 7
PFIZER INC. $1,750.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25,332.80 32
PY2019 $30,390.88 53
PY2020 $12,533.00 2
PY2021 $8,748.94 14
PY2022 $27,611.34 16
PY2023 $35,894.67 23
PY2024 $41,448.07 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
BioMarin Pharmaceutical Inc. $60.00 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1127059517 CMS
BioMarin Pharmaceutical Inc. $233.95 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1127059535 CMS
BioMarin Pharmaceutical Inc. $303.97 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1127059549 CMS
BioMarin Pharmaceutical Inc. $107.23 09/07/2024 Food and Beverage Undisputed 01/23/2026 1127059571 CMS
BioMarin Pharmaceutical Inc. $124.79 09/07/2024 Food and Beverage Undisputed 01/23/2026 1127059585 CMS
BioMarin Pharmaceutical Inc. $86.61 09/07/2024 Food and Beverage Undisputed 01/23/2026 1127059599 CMS
BioMarin Pharmaceutical Inc. $4,830.00 09/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127059609 CMS
BioMarin Pharmaceutical Inc. $1,207.88 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1127057531 CMS
BioMarin Pharmaceutical Inc. $3,864.00 10/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127063082 CMS
GENZYME CORPORATION $584.12 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1139738722 CMS
GENZYME CORPORATION $263.35 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1139738724 CMS
GENZYME CORPORATION $264.33 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1139738726 CMS
GENZYME CORPORATION $140.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139738728 CMS
GENZYME CORPORATION $50.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139738730 CMS
GENZYME CORPORATION $100.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139738732 CMS
GENZYME CORPORATION $70.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139738734 CMS
GENZYME CORPORATION $12,032.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 1139738736 CMS
GENZYME CORPORATION $78.82 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1139738738 CMS
GENZYME CORPORATION $16.62 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1139738740 CMS
GENZYME CORPORATION $5,412.00 09/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139738838 CMS
Novo Nordisk Inc $550.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1097490138 CMS
Novo Nordisk Inc $32.76 11/01/2024 Travel and Lodging Undisputed 01/23/2026 1096678273 CMS
Novo Nordisk Inc $357.00 11/01/2024 Travel and Lodging Undisputed 01/23/2026 1097496265 CMS
Novo Nordisk Inc $8,112.50 11/01/2024 Consulting Fee Undisputed 01/23/2026 1097496875 CMS
Novo Nordisk Inc $281.37 11/01/2024 Travel and Lodging Undisputed 01/23/2026 1097497615 CMS
Novo Nordisk Inc $287.00 11/01/2024 Travel and Lodging Undisputed 01/23/2026 1097498783 CMS
Novo Nordisk Inc $247.77 11/01/2024 Food and Beverage Undisputed 01/23/2026 1097499393 CMS
PFIZER INC. $1,750.00 10/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132024321 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.